UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 231

Sortiert nach

Prospects for Control of Herpes Simplex Virus Disease through Immunization

Clinical infectious diseases, 2000-03, Vol.30 (3), p.549-566

2000

Link zum Volltext

Verfügbarkeit prüfen

Dendrimers, a New Class of Candidate Topical Microbicides with Activity against Herpes Simplex Virus Infection

Antimicrobial Agents and Chemotherapy, 2000-09, Vol.44 (9), p.2471-2474

2000

Link zum Volltext

Verfügbarkeit prüfen

Evaluations of Unformulated and Formulated Dendrimer-Based Microbicide Candidates in Mouse and Guinea Pig Models of Genital Herpes

Antimicrobial Agents and Chemotherapy, 2003-12, Vol.47 (12), p.3784-3788

2003

Link zum Volltext

Verfügbarkeit prüfen

Safety and Immunogenicity of Glycoprotein D—Adjuvant Genital Herpes Vaccine

Clinical infectious diseases, 2005-05, Vol.40 (9), p.1271-1281

2005

Link zum Volltext

Verfügbarkeit prüfen

Longitudinal Risk of Herpes Simplex Virus (HSV) Type 1, HSV Type 2, and Cytomegalovirus Infections among Young Adolescent Girls

Clinical infectious diseases, 2004-11, Vol.39 (10), p.1433-1438

2004

Link zum Volltext

Verfügbarkeit prüfen

Early Intervention with High-Dose Acyclovir Treatment during Primary Herpes Simplex Virus Infection Reduces Latency and Subsequent Reactivation in the Nervous System In Vivo

The Journal of infectious diseases, 2001-10, Vol.184 (8), p.964-971

2001

Link zum Volltext

Verfügbarkeit prüfen

HSV shedding

Antiviral Research, 2004-08, Vol.63 (S1), p.S19-S26

2004

Link zum Volltext

Verfügbarkeit prüfen

DNA Immunization against Experimental Genital Herpes Simplex Virus Infection

The Journal of infectious diseases, 1996-04, Vol.173 (4), p.800-807

1996

Link zum Volltext

Verfügbarkeit prüfen

Herpes simplex virus vaccines

Vaccine, 1999-03, Vol.17 (13), p.1681-1689

1999

Link zum Volltext

Verfügbarkeit prüfen

Glycoprotein-D–Adjuvant Vaccine to Prevent Genital Herpes

The New England journal of medicine, 2002-11, Vol.347 (21), p.1652-1661

2002

Link zum Volltext

Verfügbarkeit prüfen

The psychosocial impact of serological diagnosis of asymptomatic herpes simplex virus type 2 infection

Sexually transmitted infections, 2006-04, Vol.82 (2), p.154-157

2006

Link zum Volltext

Verfügbarkeit prüfen

Plant products as topical microbicide candidates: assessment of in vitro and in vivo activity against herpes simplex virus type 2

Antiviral research, 1999-07, Vol.42 (3), p.219-226

1999

Link zum Volltext

Verfügbarkeit prüfen

Seroprevalence of Herpes Simplex Virus Types 1 and 2 and Cytomegalovirus in Adolescents

Clinical infectious diseases, 1997-02, Vol.24 (2), p.135-139

1997

Link zum Volltext

Verfügbarkeit prüfen

HSV-2 transmission

Antiviral Research, 2004-08, Vol.63 (S1), p.S27-S35

2004

Link zum Volltext

Verfügbarkeit prüfen

Poly(Sodium 4-Styrene Sulfonate): An Effective Candidate Topical Antimicrobial for the Prevention of Sexually Transmitted Diseases

The Journal of infectious diseases, 2000-02, Vol.181 (2), p.770-773

2000

Link zum Volltext

Verfügbarkeit prüfen

Civamide (cis-Capsaicin) for Treatment of Primary or Recurrent Experimental Genital Herpes

Antimicrobial Agents and Chemotherapy, 1999-11, Vol.43 (11), p.2685-2688

1999

Link zum Volltext

Verfügbarkeit prüfen

Patient satisfaction with care for genital herpes: insights from a global survey

Sexually transmitted infections, 2004-06, Vol.80 (3), p.192-197

2004

Link zum Volltext

Verfügbarkeit prüfen

Poly(sodium 4-styrene sulfonate): evaluation of a topical microbicide gel against herpes simplex virus type 2 and Chlamydia trachomatis infections in mice

Clinical microbiology and infection, 2003-08, Vol.9 (8), p.816-822

2003

Link zum Volltext

Verfügbarkeit prüfen

Randomized Controlled Trial of an Adjuvanted Human Papillomavirus (HPV) Type 6 L2E7 Vaccine: Infection of External Anogenital Warts with Multiple HPV Types and Failure of Therapeutic Vaccination

The Journal of infectious diseases, 2005-12, Vol.192 (12), p.2099-2107

2005

Link zum Volltext

Verfügbarkeit prüfen

The Topical Microbicide PRO 2000 Protects against Genital Herpes Infection in a Mouse Model

The Journal of infectious diseases, 1999-07, Vol.180 (1), p.203-205

1999

Link zum Volltext

Verfügbarkeit prüfen

Herpes Simplex Virus (HSV) Type 2 Glycoprotein D Subunit Vaccines and Protection against Genital HSV-1 or HSV-2 Disease in Guinea Pigs

The Journal of infectious diseases, 2003-02, Vol.187 (4), p.542-549

2003

Link zum Volltext

Verfügbarkeit prüfen

Impact of Immunization with Glycoprotein D2/AS04 on Herpes Simplex Virus Type 2 Shedding into the Genital Tract in Guinea Pigs That Become Infected

The Journal of infectious diseases, 2005-12, Vol.192 (12), p.2117-2123

2005

Link zum Volltext

Verfügbarkeit prüfen

Editorial Response: Asymptomatic Herpes Simplex Virus Shedding and Russian Roulette

Clinical infectious diseases, 2000-02, Vol.30 (2), p.268-269

Stanberry, Lawrence R

2000

Link zum Volltext

Verfügbarkeit prüfen

Use of Immunostimulatory Sequence-Containing Oligonucleotides as Topical Therapy for Genital Herpes Simplex Virus Type 2 Infection

Journal of Virology, 2002-11, Vol.76 (22), p.11387-11396

2002

Link zum Volltext

Verfügbarkeit prüfen

DNA immunization confers protective immunity on mice challenged intravaginally with herpes simplex virus type 2

Vaccine, 1996-09, Vol.14 (13), p.1230-1234

1996

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 231

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(215)
Mit Volltextzugriff
(182)

Publikationsform

Sprache

Englisch
(231)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prospects for Control of Herpes Simplex Virus Disease through Immunization

Dendrimers, a New Class of Candidate Topical Microbicides with Activity against Herpes Simplex Virus Infection

Evaluations of Unformulated and Formulated Dendrimer-Based Microbicide Candidates in Mouse and Guinea Pig Models of Genital Herpes

Safety and Immunogenicity of Glycoprotein D—Adjuvant Genital Herpes Vaccine

Longitudinal Risk of Herpes Simplex Virus (HSV) Type 1, HSV Type 2, and Cytomegalovirus Infections among Young Adolescent Girls

Early Intervention with High-Dose Acyclovir Treatment during Primary Herpes Simplex Virus Infection Reduces Latency and Subsequent Reactivation in the Nervous System In Vivo

HSV shedding

DNA Immunization against Experimental Genital Herpes Simplex Virus Infection

Herpes simplex virus vaccines

Glycoprotein-D–Adjuvant Vaccine to Prevent Genital Herpes

The psychosocial impact of serological diagnosis of asymptomatic herpes simplex virus type 2 infection

Plant products as topical microbicide candidates: assessment of in vitro and in vivo activity against herpes simplex virus type 2

Seroprevalence of Herpes Simplex Virus Types 1 and 2 and Cytomegalovirus in Adolescents

HSV-2 transmission

Poly(Sodium 4-Styrene Sulfonate): An Effective Candidate Topical Antimicrobial for the Prevention of Sexually Transmitted Diseases

Civamide (cis-Capsaicin) for Treatment of Primary or Recurrent Experimental Genital Herpes

Patient satisfaction with care for genital herpes: insights from a global survey

Poly(sodium 4-styrene sulfonate): evaluation of a topical microbicide gel against herpes simplex virus type 2 and Chlamydia trachomatis infections in mice

Randomized Controlled Trial of an Adjuvanted Human Papillomavirus (HPV) Type 6 L2E7 Vaccine: Infection of External Anogenital Warts with Multiple HPV Types and Failure of Therapeutic Vaccination

The Topical Microbicide PRO 2000 Protects against Genital Herpes Infection in a Mouse Model

Herpes Simplex Virus (HSV) Type 2 Glycoprotein D Subunit Vaccines and Protection against Genital HSV-1 or HSV-2 Disease in Guinea Pigs

Impact of Immunization with Glycoprotein D2/AS04 on Herpes Simplex Virus Type 2 Shedding into the Genital Tract in Guinea Pigs That Become Infected

Editorial Response: Asymptomatic Herpes Simplex Virus Shedding and Russian Roulette

Use of Immunostimulatory Sequence-Containing Oligonucleotides as Topical Therapy for Genital Herpes Simplex Virus Type 2 Infection

DNA immunization confers protective immunity on mice challenged intravaginally with herpes simplex virus type 2

Suchergebnisse filtern